Researchers will join a new NIH-supported network working to develop novel approach methodologies that complement or replace animal testing ...

According to data from a new peer-reviewed, real-world study, the "standard" Semen Analysis test can come back "normal" ...

Amid these staggering projections, there are still many unknowns about neurodegenerative diseases and memory loss, but within ...

‘Significant step’ made in creating breakthrough blood test to detect brain tumours - A new blood test is being developed by scientists to help detect brain tumours ...

SALT LAKE CITY, UT / ACCESS Newswire / March 17, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, ...

Background Individual screening for colorectal cancer (CRC) is typically performed through either direct clinical examination ...

Strategic competition in the Indo-Pacific will unfold in boardrooms and naval exercises, but also on playing fields, courts and sailing waters.

Who should be in Thomas Tuchels England squad for the March friendlies with Uruguay and Japan this month? Follow all the ...

Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

According to data from a new peer-reviewed, real-world study, the "standard" Semen Analysis test can come back "normal" and still miss problems that affect a couple's chances of getting pregnant. SALT ...

Scientists have made a “significant step” towards creating a blood test that detects brain tumours and monitors them in real time. The new test is over 90% accurate and could be used by GPs to pick up ...

Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript March 18, 2026 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.15768, expectations were $-0.18897.